Min Seob Lee

Dr. Min Seob Lee is the CEO, co-founder and co-chairman of the board of Diagnomics Inc, in San Diego, CA. He also serves as the co-CEO of the Eone Diagnomics Genome Center (KOSDAQ; EDGC) in Incheon South Korea. He is a visiting professor at the Institute of Convergence Science & Technology in Incheon National University and a director of ShareGenome in California which promotes research in precision medicine and scientific discoveries from genomics and health data. Dr. Lee is a writer of the “Homo Hundred Genome Revolution” book and published numerous scientific articles.

Diagnomics is one of the first whole genome sequencing (WGS) based genomics and bioinformatics companies with expertise in personal genome annotation and interpretation for personalized medicine. EDGC is a joint venture between EONE Life Science and Diagnomics, Inc. that focuses on clinical and consumer genomic application development and service offering using next-generation sequencing and microarray technology. Dr. Lee has established multiple companies and institutes in Genomics and Personalized Medicine industries globally. He is a world-renowned scholar, researcher, and entrepreneur in Genomics and an outstanding leader in healthcare and biotech industries and their implementation for personalized medicine and diagnostics development for precision medicine. He has extensive global experience and presence in the life sciences, healthcare, and IT business area including biotech, pharmaceutical, and diagnostics companies with expertise in personal genomics, big-data processing, artificial intelligence (AI), and pharmacogenomics, bioinformatics, and molecular diagnostics. Prior to his current role and responsibilities, he held several positions at Sequenom in San Diego, CA, and Genaissance Pharmaceuticals in New Haven, CT within their diagnostic development and genomics lab operations.